9-127826640-CG-CGGG

Variant names:

• chr9-127826640-C-CGG
• NM_001114753.3:c.391_392dupCC

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1 PM2 PP5_Moderate

The NM_001114753.3(ENG):​c.391_392dupCC​(p.Gly132ArgfsTer32) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

• Frequency: Genomes: not found (cov: 32)
• Consequence: ENG NM_001114753.3 frameshift
• Clinical Significance: Pathogenic criteria provided, single submitter P:1
• Conservation: PhyloP100: -0.0560

Genes affected

ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]

ACMG classification

Verdict is Pathogenic. Variant got 12 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 9-127826640-C-CGG is Pathogenic according to our data. Variant chr9-127826640-C-CGG is described in ClinVar as [Pathogenic]. Clinvar id is 1736116.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ENG	NM_001114753.3	c.391_392dupCC	p.Gly132ArgfsTer32	frameshift_variant	Exon 4 of 15	ENST00000373203.9	NP_001108225.1
ENG	NM_000118.4	c.391_392dupCC	p.Gly132ArgfsTer32	frameshift_variant	Exon 4 of 14		NP_000109.1
ENG	NM_001406715.1	c.391_392dupCC	p.Gly132ArgfsTer32	frameshift_variant	Exon 4 of 8		NP_001393644.1
ENG	NM_001278138.2	c.-156_-155dupCC		5_prime_UTR_variant	Exon 4 of 15		NP_001265067.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ENG	ENST00000373203.9	c.391_392dupCC	p.Gly132ArgfsTer32	frameshift_variant	Exon 4 of 15	1	NM_001114753.3	ENSP00000362299.4
ENG	ENST00000344849.4	c.391_392dupCC	p.Gly132ArgfsTer32	frameshift_variant	Exon 4 of 14	1		ENSP00000341917.3
ENG	ENST00000480266.6	c.-156_-155dupCC		5_prime_UTR_variant	Exon 4 of 15	2		ENSP00000479015.1
ENG	ENST00000462196.1	n.291_292dupCC		non_coding_transcript_exon_variant	Exon 3 of 4	3		ENSP00000519251.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 32

GnomAD4 genome Cov.: 32

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:1

Revision: criteria provided, single submitter

Submissions by phenotype

Cardiovascular phenotype Pathogenic:1

Mar 23, 2015

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.391_392dupCC pathogenic mutation, located in coding exon 4 of the ENG gene, results from a duplication of CC at nucleotide positions 391 and 392, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -

Computational scores

Source: dbNSFP v4.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-130588919;